Managing Hypertension in Patients with CKD

A Marathon, Not a SPRINT

Glenn M. Chertow, Srinivasan Beddhu, Julia B. Lewis, Robert D. Toto, Alfred K. Cheung

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

In this manuscript, nephrologist-investigators from one of five Clinical Center Networks of the Systolic Blood Pressure Intervention Trial (SPRINT) provide background information and context on the intensity of anti-hypertensive therapy in conjunction with the release of detailed results from SPRINTs primary analysis. The authors highlight published evidence on the safety and efficacy of differing intensities of anti-hypertensive therapy in mild to moderate CKD, where SPRINT will help to inform practice, as well as where gaps in evidence will remain. The authors also challenge the nephrology community to renew its attention and efforts on hypertension clinical care and research.

Original languageEnglish (US)
Pages (from-to)40-43
Number of pages4
JournalJournal of the American Society of Nephrology
Volume27
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

Blood Pressure
Hypertension
Antihypertensive Agents
Nephrology
Research Personnel
Safety
Therapeutics
Research
Nephrologists

ASJC Scopus subject areas

  • Nephrology

Cite this

Managing Hypertension in Patients with CKD : A Marathon, Not a SPRINT. / Chertow, Glenn M.; Beddhu, Srinivasan; Lewis, Julia B.; Toto, Robert D.; Cheung, Alfred K.

In: Journal of the American Society of Nephrology, Vol. 27, No. 1, 01.01.2016, p. 40-43.

Research output: Contribution to journalArticle

Chertow, Glenn M. ; Beddhu, Srinivasan ; Lewis, Julia B. ; Toto, Robert D. ; Cheung, Alfred K. / Managing Hypertension in Patients with CKD : A Marathon, Not a SPRINT. In: Journal of the American Society of Nephrology. 2016 ; Vol. 27, No. 1. pp. 40-43.
@article{1d156ea5fbc642aead96f51ff611736b,
title = "Managing Hypertension in Patients with CKD: A Marathon, Not a SPRINT",
abstract = "In this manuscript, nephrologist-investigators from one of five Clinical Center Networks of the Systolic Blood Pressure Intervention Trial (SPRINT) provide background information and context on the intensity of anti-hypertensive therapy in conjunction with the release of detailed results from SPRINTs primary analysis. The authors highlight published evidence on the safety and efficacy of differing intensities of anti-hypertensive therapy in mild to moderate CKD, where SPRINT will help to inform practice, as well as where gaps in evidence will remain. The authors also challenge the nephrology community to renew its attention and efforts on hypertension clinical care and research.",
author = "Chertow, {Glenn M.} and Srinivasan Beddhu and Lewis, {Julia B.} and Toto, {Robert D.} and Cheung, {Alfred K.}",
year = "2016",
month = "1",
day = "1",
doi = "10.1681/ASN.2015101125",
language = "English (US)",
volume = "27",
pages = "40--43",
journal = "Journal of the American Society of Nephrology",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "1",

}

TY - JOUR

T1 - Managing Hypertension in Patients with CKD

T2 - A Marathon, Not a SPRINT

AU - Chertow, Glenn M.

AU - Beddhu, Srinivasan

AU - Lewis, Julia B.

AU - Toto, Robert D.

AU - Cheung, Alfred K.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - In this manuscript, nephrologist-investigators from one of five Clinical Center Networks of the Systolic Blood Pressure Intervention Trial (SPRINT) provide background information and context on the intensity of anti-hypertensive therapy in conjunction with the release of detailed results from SPRINTs primary analysis. The authors highlight published evidence on the safety and efficacy of differing intensities of anti-hypertensive therapy in mild to moderate CKD, where SPRINT will help to inform practice, as well as where gaps in evidence will remain. The authors also challenge the nephrology community to renew its attention and efforts on hypertension clinical care and research.

AB - In this manuscript, nephrologist-investigators from one of five Clinical Center Networks of the Systolic Blood Pressure Intervention Trial (SPRINT) provide background information and context on the intensity of anti-hypertensive therapy in conjunction with the release of detailed results from SPRINTs primary analysis. The authors highlight published evidence on the safety and efficacy of differing intensities of anti-hypertensive therapy in mild to moderate CKD, where SPRINT will help to inform practice, as well as where gaps in evidence will remain. The authors also challenge the nephrology community to renew its attention and efforts on hypertension clinical care and research.

UR - http://www.scopus.com/inward/record.url?scp=84954437495&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954437495&partnerID=8YFLogxK

U2 - 10.1681/ASN.2015101125

DO - 10.1681/ASN.2015101125

M3 - Article

VL - 27

SP - 40

EP - 43

JO - Journal of the American Society of Nephrology

JF - Journal of the American Society of Nephrology

SN - 1046-6673

IS - 1

ER -